Zera®, a novel technology for stable accumulation and easy recovery of recombinant proteins in eukaryotic protein-production hosts

HIV-1 envelope glycoprotein (Env) remains the most relevant target for the elicitation of functional antibodies to HIV by vaccination. However, soluble Env antigens often do not elicit the desired immune responses. Delivering subunit antigens on particulate nanoparticles is an established approach to improve their immunogenicity. In this study the sequence encoding Zera R , a proline-rich domain derived from the γ -zein storage protein, was fused to either the C-or N-terminus of the superinfecting HIV-1 CAP256 gp140 envelope: Zera R generally induces the formation of protein bodies (PBs), which can significantly improve both the immunogenicity and yields of the partner protein. The expression of gp140-Zera R and Zera R -gp140 (N-and C-terminal fusions respectively) in mammalian cells was confirmed by western blot analysis and immunostaining. However, isopycnic ultracentrifugation showed that neither gp140-Zera R nor Zera R -gp140 accumulated in characteristic electron-dense PBs. gp140-Zera R elicited higher binding antibody titers in rabbits to autologous gp140 and V1V2 scaffold than Zera R -gp140. Rabbit anti-gp140-Zera R sera also had significantly higher Tier 1A neutralizing antibody titers than anti-Zera R -gp140 sera. Neither gp140-Zera R nor Zera R -gp140specific sera neutralized Tier 1B or autologous Tier 2 viruses. These results showed that HIV-1 gp140 tagged with Zera R at either the N-or C-termini elicited high titers of gp140 and V1V2 binding antibodies, and low levels of Tier 1 neutralizing antibodies in rabbits.

show abstract

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens

Ximba

Chapman

Meyers

et al. 2020

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Zera®, a novel technology for stable accumulation and easy recovery of recombinant proteins in eukaryotic protein-production hosts

Cited by 1 publication

References 0 publications

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens

Contact Info

Product

Resources

About